LIVE LONGER - LIVE BETTER - LIVE YOUNGER
Newly Secured Inventory Funding and Global Expansion Position the Company for Scalable Growth Amid Accelerating Demand
NAPLES, FL / ACCESS Newswire / June 23, 2026 / Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer Charles S. Arnold and President and Chief Operating Officer John W. Meyer, outlining the Company's strategic progress in 2025 and the initiatives positioning the Company for growth in 2026 and beyond.
To Our Shareholders:
2025 was a year of discipline, realignment and strategic execution for Stemtech Corporation.
